Selected 2006 Strategic Alliances, Joint Venture and Licensing Transactions

Selected 2006 Strategic Alliances, Joint Venture and Licensing Transactions

Publication
  • Airwide Solutions — US and international reseller and sales agreements
  • Alantos Pharmaceuticals — Collaboration with Servier for oral administration treatment for type 2 diabetes
  • Alnylam Pharmaceuticals — Collaboration with Novartis Institutes for BioMedical Research to develop RNAi therapeutics for pandemic flu
  • Applix — International software solution partner agreement
  • AVEO Pharmaceuticals — License from Kirin Brewery of clinical-stage cancer product
  • Avid Technology — Key licensing, distribution and supply agreements for Avid Technology and its Digidesign division
  • Bose — Various licensing and collaboration matters
  • Braintree Laboratories — License to Schering-Plough of MiraLAX® over-the-counter gastrointestinal products
  • Broadcom — Licenses in connection with various acquisitions
  • Brooks Automation — Formation of Japanese joint venture with Yaskawa Electric
  • Cephalon — Licensing advice in connection with settlements of Provigil® generic patent infringement litigation
  • Constant Contact — Various co-promotion and licensing matters
  • Emergent BioSolutions — Supply agreements for a therapeutic anthrax immune globulin product
  • From the Top — Agreements with WGBH, Carnegie Hall and others for production of public television series
  • Idera Pharmaceuticals — Collaboration with Merck to develop vaccines incorporating toll-like receptor agonists
  • IETF — Advice to the leading standards body for the Internet
  • IGA Worldwide — Online game advertising agreement with Electronic Arts
  • Infinity Pharmaceuticals — Alliance with MedImmune for novel small molecule cancer drugs
  • Momenta Pharmaceuticals — Alliance with Sandoz to develop complex generic and follow-on biotechnology drugs
  • Palm — Various patent licenses
  • Panera Bread — Licensing and supply arrangements for Canadian retail expansion
  • PTC Therapeutics — Collaboration with Schering-Plough for the development of hepatitis C virus drugs
  • ReGen Therapeutics — Distribution and marketing of nutraceutical compounds through Metagenics
  • SiCortex — Various development, manufacturing, services and distribution agreements
  • Silicon Integration Initiative — Formation of low-power integrated circuit design flow coalition
  • Starent Networks — International distribution agreements and licensing transactions
  • Sucampo Pharmaceuticals — Licensing advice in connection with corporate reorganization
  • Syntonix Pharmaceuticals — Strategic alliance with Biovitrum for long-acting hemophilia B product
  • Xanthus — Acquisition from Schering AG of rights to clinical-stage cancer compounds
  • Ziopharm — Acquisition from Baxter Healthcare of clinical-stage anti-cancer agent program

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.